Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Importance of Virus Characteristics in Respiratory Syncytial Virus-Induced Disease.

San-Juan-Vergara H, Peeples ME.

Immunol Allergy Clin North Am. 2019 Aug;39(3):321-334. doi: 10.1016/j.iac.2019.04.001. Epub 2019 May 22. Review.

PMID:
31284923
2.

Post-viral atopic airway disease: pathogenesis and potential avenues for intervention.

Hussain SA, Mejias A, Ramilo O, Peeples ME, Grayson MH.

Expert Rev Clin Immunol. 2019 Jan;15(1):49-58. doi: 10.1080/1744666X.2019.1541737. Epub 2018 Nov 3.

PMID:
30370798
3.

A Zika virus vaccine expressing premembrane-envelope-NS1 polyprotein.

Li A, Yu J, Lu M, Ma Y, Attia Z, Shan C, Xue M, Liang X, Craig K, Makadiya N, He JJ, Jennings R, Shi PY, Peeples ME, Liu SL, Boyaka PN, Li J.

Nat Commun. 2018 Aug 3;9(1):3067. doi: 10.1038/s41467-018-05276-4.

4.

The psychoactive substance of cannabis Δ9-tetrahydrocannabinol (THC) negatively regulates CFTR in airway cells.

Chang SW, Wellmerling J, Zhang X, Rayner RE, Osman W, Mertz S, Amer AO, Peeples ME, Boyaka PN, Cormet-Boyaka E.

Biochim Biophys Acta Gen Subj. 2018 Sep;1862(9):1988-1994. doi: 10.1016/j.bbagen.2018.06.008. Epub 2018 Jun 19.

PMID:
29928919
5.

A viral-vectored RSV vaccine induces long-lived humoral immunity in cotton rats.

Grieves JL, Yin Z, Garcia-Sastre A, Mena I, Peeples ME, Risman HP, Federman H, Sandoval MJ, Durbin RK, Durbin JE.

Vaccine. 2018 Jun 18;36(26):3842-3852. doi: 10.1016/j.vaccine.2018.04.089. Epub 2018 May 18.

6.

Five Residues in the Apical Loop of the Respiratory Syncytial Virus Fusion Protein F2 Subunit Are Critical for Its Fusion Activity.

Hicks SN, Chaiwatpongsakorn S, Costello HM, McLellan JS, Ray W, Peeples ME.

J Virol. 2018 Jul 17;92(15). pii: e00621-18. doi: 10.1128/JVI.00621-18. Print 2018 Aug 1.

7.

Respiratory Syncytial Virus Genotypes, Host Immune Profiles, and Disease Severity in Young Children Hospitalized With Bronchiolitis.

Rodriguez-Fernandez R, Tapia LI, Yang CF, Torres JP, Chavez-Bueno S, Garcia C, Jaramillo LM, Moore-Clingenpeel M, Jafri HS, Peeples ME, Piedra PA, Ramilo O, Mejias A.

J Infect Dis. 2017 Dec 27;217(1):24-34. doi: 10.1093/infdis/jix543.

8.

Prefusion F, Postfusion F, G Antibodies, and Disease Severity in Infants and Young Children With Acute Respiratory Syncytial Virus Infection.

Capella C, Chaiwatpongsakorn S, Gorrell E, Risch ZA, Ye F, Mertz SE, Johnson SM, Moore-Clingenpeel M, Ramilo O, Mejias A, Peeples ME.

J Infect Dis. 2017 Dec 12;216(11):1398-1406. doi: 10.1093/infdis/jix489.

9.

Efficient method for site-directed mutagenesis in large plasmids without subcloning.

Hallak LK, Berger K, Kaspar R, Kwilas AR, Montanaro F, Peeples ME.

PLoS One. 2017 Jun 2;12(6):e0177788. doi: 10.1371/journal.pone.0177788. eCollection 2017.

10.

Development and clinical applications of novel antibodies for prevention and treatment of respiratory syncytial virus infection.

Mejias A, Garcia-Maurino C, Rodriguez-Fernandez R, Peeples ME, Ramilo O.

Vaccine. 2017 Jan 11;35(3):496-502. doi: 10.1016/j.vaccine.2016.09.026. Epub 2016 Sep 28. Review.

11.

Respiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial Cultures.

Johnson SM, McNally BA, Ioannidis I, Flano E, Teng MN, Oomens AG, Walsh EE, Peeples ME.

PLoS Pathog. 2015 Dec 11;11(12):e1005318. doi: 10.1371/journal.ppat.1005318. eCollection 2015 Dec.

12.

Molecular mechanism of respiratory syncytial virus fusion inhibitors.

Battles MB, Langedijk JP, Furmanova-Hollenstein P, Chaiwatpongsakorn S, Costello HM, Kwanten L, Vranckx L, Vink P, Jaensch S, Jonckers TH, Koul A, Arnoult E, Peeples ME, Roymans D, McLellan JS.

Nat Chem Biol. 2016 Feb;12(2):87-93. doi: 10.1038/nchembio.1982. Epub 2015 Dec 7.

13.

Preventing Cleavage of the Respiratory Syncytial Virus Attachment Protein in Vero Cells Rescues the Infectivity of Progeny Virus for Primary Human Airway Cultures.

Corry J, Johnson SM, Cornwell J, Peeples ME.

J Virol. 2015 Nov 18;90(3):1311-20. doi: 10.1128/JVI.02351-15. Print 2016 Feb 1.

14.

Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera.

Ngwuta JO, Chen M, Modjarrad K, Joyce MG, Kanekiyo M, Kumar A, Yassine HM, Moin SM, Killikelly AM, Chuang GY, Druz A, Georgiev IS, Rundlet EJ, Sastry M, Stewart-Jones GB, Yang Y, Zhang B, Nason MC, Capella C, Peeples ME, Ledgerwood JE, McLellan JS, Kwong PD, Graham BS.

Sci Transl Med. 2015 Oct 14;7(309):309ra162. doi: 10.1126/scitranslmed.aac4241.

15.

Citrus transformation using mature tissue explants.

Orbović V, Shankar A, Peeples ME, Hubbard C, Zale J.

Methods Mol Biol. 2015;1224:259-73. doi: 10.1007/978-1-4939-1658-0_21.

PMID:
25416264
16.

Roles of the putative integrin-binding motif of the human metapneumovirus fusion (f) protein in cell-cell fusion, viral infectivity, and pathogenesis.

Wei Y, Zhang Y, Cai H, Mirza AM, Iorio RM, Peeples ME, Niewiesk S, Li J.

J Virol. 2014 Apr;88(8):4338-52. doi: 10.1128/JVI.03491-13. Epub 2014 Jan 29.

17.

Structure and function of respiratory syncytial virus surface glycoproteins.

McLellan JS, Ray WC, Peeples ME.

Curr Top Microbiol Immunol. 2013;372:83-104. doi: 10.1007/978-3-642-38919-1_4. Review.

18.

Interstitial lung disease in a child with antisynthetase syndrome.

Hayes D Jr, Baker PB, Mansour HM, Peeples ME, Nicol KK.

Lung. 2013 Aug;191(4):441-3. doi: 10.1007/s00408-013-9468-2. Epub 2013 May 8.

PMID:
23652349
19.

Distinct and overlapping roles of Nipah virus P gene products in modulating the human endothelial cell antiviral response.

Lo MK, Peeples ME, Bellini WJ, Nichol ST, Rota PA, Spiropoulou CF.

PLoS One. 2012;7(10):e47790. doi: 10.1371/journal.pone.0047790. Epub 2012 Oct 19.

20.

Replication of respiratory syncytial virus is inhibited by the host defense molecule viperin.

McGillivary G, Jordan ZB, Peeples ME, Bakaletz LO.

J Innate Immun. 2013;5(1):60-71. doi: 10.1159/000342473. Epub 2012 Sep 25.

21.

Plasticity and virus specificity of the airway epithelial cell immune response during respiratory virus infection.

Ioannidis I, McNally B, Willette M, Peeples ME, Chaussabel D, Durbin JE, Ramilo O, Mejias A, Flaño E.

J Virol. 2012 May;86(10):5422-36. doi: 10.1128/JVI.06757-11. Epub 2012 Mar 7.

22.

Targeting RSV with vaccines and small molecule drugs.

Costello HM, Ray WC, Chaiwatpongsakorn S, Peeples ME.

Infect Disord Drug Targets. 2012 Apr;12(2):110-28. Review.

23.

Cholesterol-rich microdomains as docking platforms for respiratory syncytial virus in normal human bronchial epithelial cells.

San-Juan-Vergara H, Sampayo-Escobar V, Reyes N, Cha B, Pacheco-Lugo L, Wong T, Peeples ME, Collins PL, Castaño ME, Mohapatra SS.

J Virol. 2012 Feb;86(3):1832-43. doi: 10.1128/JVI.06274-11. Epub 2011 Nov 16. Erratum in: J Virol. 2012 May;86(9):5408.

24.

A respiratory syncytial virus replicon that is noncytotoxic and capable of long-term foreign gene expression.

Malykhina O, Yednak MA, Collins PL, Olivo PD, Peeples ME.

J Virol. 2011 May;85(10):4792-801. doi: 10.1128/JVI.02399-10. Epub 2011 Mar 9.

25.

Soluble respiratory syncytial virus fusion protein in the fully cleaved, pretriggered state is triggered by exposure to low-molarity buffer.

Chaiwatpongsakorn S, Epand RF, Collins PL, Epand RM, Peeples ME.

J Virol. 2011 Apr;85(8):3968-77. doi: 10.1128/JVI.01813-10. Epub 2011 Feb 9.

26.

Mapping the anatomy of respiratory syncytial virus infection of the upper airways in chinchillas (Chinchilla lanigera).

Grieves JL, Jurcisek JA, Quist B, Durbin RK, Peeples ME, Durbin JE, Bakaletz LO.

Comp Med. 2010 Jun;60(3):225-32.

27.

Respiratory syncytial virus engineered to express the cystic fibrosis transmembrane conductance regulator corrects the bioelectric phenotype of human cystic fibrosis airway epithelium in vitro.

Kwilas AR, Yednak MA, Zhang L, Liesman R, Collins PL, Pickles RJ, Peeples ME.

J Virol. 2010 Aug;84(15):7770-81. doi: 10.1128/JVI.00346-10. Epub 2010 May 26.

28.

Respiratory syncytial virus grown in Vero cells contains a truncated attachment protein that alters its infectivity and dependence on glycosaminoglycans.

Kwilas S, Liesman RM, Zhang L, Walsh E, Pickles RJ, Peeples ME.

J Virol. 2009 Oct;83(20):10710-8. doi: 10.1128/JVI.00986-09. Epub 2009 Aug 5.

29.

Respiratory syncytial virus-induced dysregulation of expression of a mucosal beta-defensin augments colonization of the upper airway by non-typeable Haemophilus influenzae.

McGillivary G, Mason KM, Jurcisek JA, Peeples ME, Bakaletz LO.

Cell Microbiol. 2009 Sep;11(9):1399-408. doi: 10.1111/j.1462-5822.2009.01339.x. Epub 2009 Jun 2.

30.

Aetiology of influenza-like illness in adults includes parainfluenzavirus type 4.

Hasman H, Pachucki CT, Unal A, Nguyen D, Devlin T, Peeples ME, Kwilas SA.

J Med Microbiol. 2009 Apr;58(Pt 4):408-13. doi: 10.1099/jmm.0.006098-0.

31.

Determination of the henipavirus phosphoprotein gene mRNA editing frequencies and detection of the C, V and W proteins of Nipah virus in virus-infected cells.

Lo MK, Harcourt BH, Mungall BA, Tamin A, Peeples ME, Bellini WJ, Rota PA.

J Gen Virol. 2009 Feb;90(Pt 2):398-404. doi: 10.1099/vir.0.007294-0.

PMID:
19141449
32.

Interaction between respiratory syncytial virus and glycosaminoglycans, including heparan sulfate.

Hallak LK, Kwilas SA, Peeples ME.

Methods Mol Biol. 2007;379:15-34. Review.

PMID:
17502668
33.
34.

Requirements for the assembly and release of Newcastle disease virus-like particles.

Pantua HD, McGinnes LW, Peeples ME, Morrison TG.

J Virol. 2006 Nov;80(22):11062-73. Epub 2006 Sep 13. Erratum in: J Virol. 2007 Feb;81(3):1537.

35.

Respiratory syncytial virus infection reduces beta2-adrenergic responses in human airway smooth muscle.

Moore PE, Cunningham G, Calder MM, DeMatteo AD Jr, Peeples ME, Summar ML, Peebles RS Jr.

Am J Respir Cell Mol Biol. 2006 Nov;35(5):559-64. Epub 2006 Jun 8.

36.

Differential response of dendritic cells to human metapneumovirus and respiratory syncytial virus.

Guerrero-Plata A, Casola A, Suarez G, Yu X, Spetch L, Peeples ME, Garofalo RP.

Am J Respir Cell Mol Biol. 2006 Mar;34(3):320-9. Epub 2005 Nov 11. Erratum in: Am J Respir Cell Mol Biol. 2006 May;34(5):643.

37.

RhoA signaling is required for respiratory syncytial virus-induced syncytium formation and filamentous virion morphology.

Gower TL, Pastey MK, Peeples ME, Collins PL, McCurdy LH, Hart TK, Guth A, Johnson TR, Graham BS.

J Virol. 2005 May;79(9):5326-36.

38.

Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium.

Zhang L, Bukreyev A, Thompson CI, Watson B, Peeples ME, Collins PL, Pickles RJ.

J Virol. 2005 Jan;79(2):1113-24.

39.

Protein kinase C-alpha activity is required for respiratory syncytial virus fusion to human bronchial epithelial cells.

San-Juan-Vergara H, Peeples ME, Lockey RF, Mohapatra SS.

J Virol. 2004 Dec;78(24):13717-26.

40.

Evolution of vaccinia virus-specific CD8+ cytotoxic T-lymphocyte responses in primary vaccinees and revaccinees.

Tenorio AR, Peeples ME, Patri M, Rezai K, Trenholme GM.

Clin Diagn Lab Immunol. 2004 Jul;11(4):758-61.

41.

ERK-1/2 activity is required for efficient RSV infection.

Kong X, San Juan H, Behera A, Peeples ME, Wu J, Lockey RF, Mohapatra SS.

FEBS Lett. 2004 Feb 13;559(1-3):33-8.

42.

Completion of trimeric hairpin formation of influenza virus hemagglutinin promotes fusion pore opening and enlargement.

Borrego-Diaz E, Peeples ME, Markosyan RM, Melikyan GB, Cohen FS.

Virology. 2003 Nov 25;316(2):234-44.

45.
46.

Mapping the transcription and replication promoters of respiratory syncytial virus.

Fearns R, Peeples ME, Collins PL.

J Virol. 2002 Feb;76(4):1663-72.

47.
48.

Newcastle disease virus therapy of human tumor xenografts: antitumor effects of local or systemic administration.

Phuangsab A, Lorence RM, Reichard KW, Peeples ME, Walter RJ.

Cancer Lett. 2001 Oct 22;172(1):27-36.

PMID:
11595126
50.

RhoA is activated during respiratory syncytial virus infection.

Gower TL, Peeples ME, Collins PL, Graham BS.

Virology. 2001 May 10;283(2):188-96.

Supplemental Content

Loading ...
Support Center